1. Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever‐increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127:3029–30.
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209–49.
3. Bilginer S, Bardaweel SK, Sabbah DA, Gul HI. Docking studies and antiproliferative activities of 6-(3-aryl-2-propenoyl)-2 (3h)-benzoxazolone derivatives as novel inhibitors of phosphatidylinositol 3-kinase (PI3Kα). Anti-Cancer Agents Medicinal Chem (Former Curr Medicinal Chem-Anti-Cancer Agents). 2021;21:716–24.
4. Raghavendra NM, Pingili D, Kadasi S, Mettu A, Prasad S. Dual or multi-targeting inhibitors: the next generation anticancer agents. Eur J Medicinal Chem. 2018;143:1277–300.
5. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Medicinal Chem Lett. 2010;20:3467–74.